Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?Tze‐Fan Chao, Shih‐Ann Chen, Chia‐Jen Liu et al.|Journal of the American College of Cardiology|2015Cited by 258
Oral Anticoagulation in Very Elderly Patients With Atrial FibrillationTze‐Fan Chao, Shih‐Ann Chen, Chia‐Jen Liu et al.|Circulation|2018Cited by 221
Using the CHA2DS2-VASc Score for Refining Stroke Risk Stratification in ‘Low-Risk’ Asian Patients With Atrial FibrillationTze‐Fan Chao, Shih‐Ann Chen, Yenn‐Jiang Lin et al.|Journal of the American College of Cardiology|2014Cited by 174
Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk FactorsTze‐Fan Chao, Shih‐Ann Chen, Yenn‐Jiang Lin et al.|Thrombosis and Haemostasis|2018Cited by 165
Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial HemorrhageTze‐Fan Chao, Shih‐Ann Chen, Chia‐Jen Liu et al.|Circulation|2016Cited by 116